+39 02 610346.1 - info@newron.com

Latest press releases

  • 23May
    Zambon Launches Xadago® (Safinamide) In The U.K. For Patients With Mid- To Late-Stage Parkinson’s Disease


  • 17May
    Newron Announces IND Approval for Sarizotan for Treatment of Rett Syndrome


  • 28Apr
    Zambon Launches Xadago® (Safinamide) In Denmark And Sweden For Patients With Mid-To Late Stage Parkinson’s Disease


  • 11Apr
    Newron Pharmaceuticals and partner Zambon support Parkinson's disease Awareness Day 2016


  • 5Apr
    Ongoing Phase II Study of Evenamide (NW-3509) May Suggest an Alternative Approach to the Treatment of Schizophrenia


  • 4Apr
    Zambon Launches Xadago® (Safinamide) in Belgium for Patients With Mid-To Late Stage Parkinson’s Disease


View All

Newron share price


  • 23Aug
    Bellevue Healthcare Day

    August 23, 2016 - Marriott Hotel, Zurich, Switzerland

  • 7Jun
    Jefferies 2016 Healthcare Conference

    June 7-10, 2016 - Grand Hyatt, New York - USA

  • 12Apr
    Swiss Biotech Day

    April 12, 2016 - Congress Center Basel, Hall 4, Basel - Switzerland

View Event Calendar